Cargando…

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers

BACKGROUND: Triple-negative breast cancer (TNBC) is highly diverse group of cancers, and generally considered an aggressive disease associated with poor survival. Stratification of TNBC is highly desired for both prognosis and treatment decisions to identify patients who may benefit from less aggres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yue, Yong, Astvatsaturyan, Kristine, Cui, Xiaojiang, Zhang, Xiao, Fraass, Benedick, Bose, Shikha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773063/ https://www.ncbi.nlm.nih.gov/pubmed/26930401 http://dx.doi.org/10.1371/journal.pone.0149661

Ejemplares similares

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
por: Yue, Yong, et al.
Publicado: (2015)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
por: Astvatsaturyan, Kristine, et al.
Publicado: (2018)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Identifying Biomarkers to Pair with Targeting Treatments within Triple Negative Breast Cancer for Improved Patient Stratification
por: Tovey, Holly, et al.
Publicado: (2019)

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

A dose‐gradient analysis tool for IMRT QA
por: Moran, Jean M., et al.
Publicado: (2005)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
por: Gao, Bowen, et al.
Publicado: (2021)

Verification of dynamic and segmental IMRT delivery by dynamic log file analysis
por: Litzenberg, Dale W., et al.
Publicado: (2002)

Protocol for stratification of triple-negative breast cancer patients using in silico signaling dynamics
por: Imoto, Hiroaki, et al.
Publicado: (2022)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer
por: Wang, Xiaojie, et al.
Publicado: (2020)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

HSPA8 Is a New Biomarker of Triple Negative Breast Cancer Related to Prognosis and Immune Infiltration
por: Ying, Bicheng, et al.
Publicado: (2022)

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer
por: Huertas-Caro, Carlos A., et al.
Publicado: (2023)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

Dosimetric comparison of extended dose range film with ionization measurements in water and lung equivalent heterogeneous media exposed to megavoltage photons
por: Charland, Paule M., et al.
Publicado: (2003)

Accuracy of rapid radiographic film calibration for intensity‐modulated radiation therapy verification
por: Kulasekere, Ravi, et al.
Publicado: (2006)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer
por: Thalor, Anamika, et al.
Publicado: (2022)

No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment
por: Mu, Lan, et al.
Publicado: (2017)

Risk Stratification Model for Predicting the Overall Survival of Elderly Triple-Negative Breast Cancer Patients: A Population-Based Study
por: Liu, Xiaozhu, et al.
Publicado: (2021)

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer
por: Colavito, Sierra A., et al.
Publicado: (2019)

Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
por: Haritha, Nair Hariprasad, et al.
Publicado: (2021)

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
por: Lamballe, Fabienne, et al.
Publicado: (2020)

Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy
por: Winter, Marie, et al.
Publicado: (2023)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
por: Shen, Songjie, et al.
Publicado: (2014)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
por: Moffa, Giuliana, et al.
Publicado: (2020)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3usiaat01cumug1as8l3ensut1